LOGIN  |  REGISTER

Neogen® Launches Igenity® Enhanced Dairy

August 15, 2023 | Last Trade: US$12.14 0.12 1.00

LINCOLN, Neb., Aug. 15, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched Igenity® Enhanced Dairy, a new and progressive genomic data management tool.

Igenity Enhanced Dairy is a new digital service that empowers dairy producers to make better selection and mating decisions. By integrating in-herd phenotypic data, pedigree information, and existing predicted transmitting abilities (PTAs) from the Council on Dairy Cattle Breeding (CDCB), the platform delivers a genomic evaluation of dairy cattle.

Producers are able to utilize the data provided by Igenity Enhanced Dairy to make an in-herd assessment of the genetic potential by pairing each animal's performance data with the results received from an Igenity Select profile. The ability to apply on-farm phenotype data to a standard genetic assessment leverages the management and geography of the individual animals to ultimately enable better decision-making.

"Neogen is thrilled to introduce a useful tool that contributes to the improvement of genetic selection in the dairy cattle market," said Dr. Victor Pedrosa, Neogen's Director of Genetic Prediction. "Data plays a crucial role in decision-making, and the Igenity Enhanced Dairy platform allows producers to take an additional step forward. The traditional genetic evaluations provided by the CDCB have significantly enhanced the genetic progress of several economically valuable traits. Now, with Igenity Enhanced Dairy, we are enabling an extra gain in the dairy selection process."

Neogen Genomics constantly provides high-quality data to assist with herd improvement and improve cattle operations, and the new Igenity Enhanced Dairy equips producers with valuable data and evaluates their herd's potential, assisting in making the most informed decisions.

To learn more about the new Igenity Enhanced Dairy test or Neogen's other genomics solutions for cattle, contact Neogen by calling 877.443.6589, email This email address is being protected from spambots. You need JavaScript enabled to view it., visit neogen.com, or contact your local Territory Manager. 

About Neogen

Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

Media Contact:

Dr. Victor Pedrosa, Director of Genetic Prediction
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB